Objective: To provide practical recommendations for the comprehensive approach of people with type 2 diabetes according to evidence-based medicine.
Participants: Members of the Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition.
Methods: The recommendations were formulated according to the degrees of evidence of the Standards of Medical Care in Diabetes-2022.
Objective: Obesity is characterized by a low-grade inflammatory state in adipose tissue. Tumor Necrosis Factor Weak Inducer of Apoptosis (TWEAK) and Cluster of Differentiation 163 (CD163) are cytokines potentially involved in the pathogenesis of obesity. Little is known about them in children.
View Article and Find Full Text PDFDapagliflozin is a selective sodium-glucose cotransporter 2 inhibitor (SGLT2i) indicated for the treatment of type 2 diabetes mellitus (T2DM), heart failure with reduced ejection fraction and chronic kidney disease. In all indications, treatment can be initiated in adults with estimated glomerular filtration rate of at least 25 mL/min/1.73 m.
View Article and Find Full Text PDF